Leptin serum levels as a marker of MRI disease activity during IFN beta therapy in multiple sclerosis

被引：0
|
作者：
Tomassini, V
Angelucci, F
Batocchi, AP
Mirabella, M
Onesti, E
Paolillo, A
Russo, P
Pozzilli, C
Tonali, PA
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A328 / A328
页数：1
相关论文
共 50 条
  • [21] Cytokine levels and disease activity in Multiple Sclerosis
    Zeitoun, I
    Miron, S
    Copel, B
    Adunsky, A
    Achiron, A
    NEUROSCIENCE LETTERS, 1998, : S46 - S46
  • [22] Changes in serum leptin levels during GnRH agonist therapy
    Douchi, T
    Kuwahata, T
    Yoshimitsu, N
    Iwamoto, I
    Yamasaki, H
    Nagata, Y
    ENDOCRINE JOURNAL, 2003, 50 (03) : 355 - 359
  • [23] Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid
    Kaushik, Deepak K.
    Yong, Heather Y. F.
    Hahn, Jennifer N.
    Silva, Claudia
    Casha, Steven
    Hurlbert, R. John
    Jacques, Francois H.
    Lisak, Robert
    Khan, Omar
    Ionete, Carolina
    Larochelle, Catherine
    Prat, Alex
    Bar-Or, Amit
    Yong, V. Wee
    PLOS ONE, 2016, 11 (10):
  • [24] Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy
    Castellazzi, Massimiliano
    Bellini, Tiziana
    Trentini, Alessandro
    Delbue, Serena
    Elia, Francesca
    Gastaldi, Matteo
    Franciotta, Diego
    Bergamaschi, Roberto
    Manfrinato, Maria Cristina
    Volta, Carlo Alberto
    Granieri, Enrico
    Fainardi, Enrico
    DISEASE MARKERS, 2016, 2016
  • [25] Serum Leptin levels in Rheumatoid arthritis and relationship with disease activity
    Abdalla, Mayada
    Effat, Dina
    Sheta, Marwa
    Hamed, Wessam Eissa
    EGYPTIAN RHEUMATOLOGIST, 2014, 36 (01): : 1 - 5
  • [26] Serum leptin levels in rheumatoid arthritis and relationship with disease activity
    Gunaydin, Rezzan
    Kaya, Taciser
    Atay, Aysenur
    Olmez, Nese
    Hur, Aysel
    Koseoglu, Mehmet
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (10) : 1078 - 1083
  • [27] High levels of soluble MIC molecules in serum are related to multiple sclerosis disease activity
    Oliva-Nacarino, P.
    Tunon, A.
    Fernandez-Morera, J. L.
    Rodriguez-Rodero, S.
    Lopez-Vazquez, A.
    Martinez-Borra, J.
    Lahoz, C. H.
    Lopez-Larrea, C.
    MULTIPLE SCLEROSIS, 2006, 12 : S58 - S58
  • [28] Monitoring of Subclinical Disease Activity by Serum Neurofilament Light Chain Levels in Multiple Sclerosis
    Uher, Tomas
    Schaedelin, Sabine
    Benova, Barbora
    Barro, Christian
    Bergsland, Niels
    Dwyer, Michael
    Tyblova, Michaela
    Kucerova, Karolina
    Benkert, Pascal
    Michalak, Zuzanna
    Leppert, David
    Naegelin, Yvonne
    Krasensky, Jan
    Seidl, Zdenek
    Vaneckova, Manuela
    Havrdova, Eva Kubala
    Kappos, Ludwig
    Zivadinov, Robert
    Horakova, Dana
    Kuhle, Jens
    Kalincik, Tomas
    NEUROLOGY, 2019, 92 (15)
  • [29] Serum levels of chitotriosidase as a marker of disease activity in sarcoidosis
    Lombardo, G.
    Giannetto, L.
    Quattrocchi, P.
    Crea, C.
    Lombardo, G.
    ALLERGY, 2009, 64 : 396 - 396
  • [30] SERUM LEVELS OF BETA-2-MICROGLOBULIN - NEW MARKER OF ACTIVITY IN CROHNS-DISEASE
    KRUIS, W
    FATEHMOGADAM, A
    SANDEL, P
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (24): : 1348 - 1348
12345